Preparation of monoclonal antibody against human tumor endothelial marker-7 extracellular fragment and study of the localization of its protein in carcinoma of different origins

张琳,郑莉,任加强,陈琦,朱虹光

DOI: https://doi.org/10.3760/j:issn:0254-5101.2004.10.007

2004-01-01

Abstract:Objective: To prepare monoclonal antibody specifically against human tumor endothelial marker-7(TEM7), then to examine the localization of TEM7 protein in solid tumors and related normal tissues of different origins by immunohistochemical staining in order to provide a valuable theoretical basis for TEM7-based vascular targeting cancer therapy. Methods: TEM7 extracellular cDNA fragment was cloned with PCR to pET-32b vector and expressed in E. coli BL21 (DE3). The purified TEM7 fusion protein was used to immunize BALB/c mice and monoclonal antibody against TEM7 extracellular fragment was prepared. The hybridoma cells were primarily screened by enzyme-linked immunoabsorbent assay (ELISA), and identified by Western blot. With the previous prepared monoclonal antibody, tumor tissues and related normal tissues were examined immunohistochemically (ABC method) for the localization of TEM7 protein. Results: A specific monoclonal antibody against human TEM7 extracellular domain was characterized by Western blot and human TEM7 protein was detected in different tumor tissue. Conclusion: The TEM7 isn't only present in tumor endothelia, but also in cancer cells, even in some normal tissues. Our results suggested that to examine the protein markers may be a more effective and reliable way in the research of vascular targeting cancer therapies.